Pregnancy outcomes after rimegepant use for migraine
Treatments studied
Part of Brain & nervous system clinical trials.
This observational study looks at health outcomes for moms, babies, and infants after rimegepant is used during pregnancy for migraine. It may help doctors understand potential risks or reassuring safety information for future pregnancies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and have a migraine diagnosis
- You took rimegepant during pregnancy or within 3 days before conception (or you did not take it at all, if you are in the unexposed group)
- If you were exposed, you had at least one dose of rimegepant at the relevant time
- If you are unexposed, you had no rimegepant before or during pregnancy
- You did not take other related migraine medicines during pregnancy or within 3 days before conception (like ubrogepant, CGRP antibody shots, or ditans such as lasmiditan)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks the health of pregnant women with migraine who take Aimovig. It helps doctors understand if the medicine is safe to use during pregnancy.
This study tests if the drug rimegepant can help prevent migraine attacks in women. It aims to see how well it works in real life in China.
This study tests a medicine called rimegepant to see if it helps prevent migraines. If you have migraine at least 4 days per month, this might be for you.
This trial studies whether rimegepant can reduce how often migraine attacks happen in children and teens. It also looks at safety and how well the treatment fits day-to-day life and school activities.
This trial tests whether a medication called rimegepant can prevent migraines when you take it before a known trigger (like exercise or stress). It is for people who get migraines often and can predict when one might happen.
This trial studies how well a “gepant” medicine works for different types of migraine and how tolerable it is. It may help if you have frequent migraines and you can keep a headache diary as the study asks.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.